ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Regístrate

¿Ya eres miembro? Iniciar sesión

Los Principales Corredores en Línea

Más Corredores en Línea

Datos
Noticias
Herramientas
Mercados
Descubrir

Hot Features

Follow Feed

Conéctese con traders e inversores en nuestra comunidad Follow Feed.

Flujo de Opciones

Explora datos de opciones completos y utiliza filtros avanzados con Options Flow.

Monitor

Organiza y monitorea tu lista de seguimiento de acciones y activos con Monitor.
Iniciar Sesión Premium IconPremium Help Menu
S&P 500
5,064.20
0.91%
Dow Jones
38,225.66
0.85%
US Dollar vs MXN
16.96129
-0.07%
Brent Oil
83.585
-0.05%
Bitcoin
59,444.74
0.55%
Registration Strip Icon for discussion Regístrate para interactuar en nuestros foros activos para discutir con inversores de ideas afines.
Regístrate
  1. Inicio
  2. Invertir
  3. Acciones
  4. Estados Unidos
  5. NASDAQ
  6. Incannex Healthcare Ltd (IXHL)

  7. Incannex Healthcare Ltd (IXHL) Noticias

IXHL Incannex Healthcare Ltd

2.55
0.00 (0.00%)
Pre Mercado
Última actualización: 03:25:25
Retrasado por 15 minutos
Nombre de la Acción Símbolo de la Acción Bolsa de Valores Tipo de Valor
Incannex Healthcare Ltd IXHL NASDAQ Acción Común
  Variación del Día (ptos.) Variación del Día (%) Último Precio Hora
Upgrade Icon
0.00 0.00% 2.55 03:25:25
Precio de Apertura Precio Mínimo Precio Máximo Precio de cierre Precio Anterior
2.55
más cotizaciones de acciones »

Noticias Recientes

Fecha Hora Fuente Noticia
16/4/202407:00GLOBEIncannex Healthcare Inc. Quarterly Update, Q1 2024
28/2/202406:30GLOBEIncannex Announces Positive Topline Results from Phase 2..
16/2/202407:00EDGAR2Form 8-K - Current report
16/2/202406:30GLOBEIncannex Completes Successful Pre-IND Meeting with the FDA..
14/2/202405:16EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
01/2/202406:30EDGAR2Form 8-K - Current report
01/2/202406:30GLOBEClarion Clinics Open for Psychedelic-Assisted Treatments
24/1/202415:30EDGAR2Form 8-K - Current report
24/1/202415:05GLOBEIncannex Commences Dosing in Phase 2 Clinical Trial..
18/1/202408:08EDGAR2Form 8-K - Current report
18/1/202407:22GLOBEIncannex Completes Dosing and Therapy in Phase 2 “PsiGAD”..
17/1/202406:30GLOBEIncannex Receives IRB Approval for the RePOSA Phase 2/3..
17/1/202405:05EDGAR2Form 8-K - Current report
22/12/202305:07EDGAR2Form 8-K - Current report
21/12/202319:54EDGAR2Form 4 - Statement of changes in beneficial ownership of..
21/12/202319:53EDGAR2Form 4 - Statement of changes in beneficial ownership of..
21/12/202319:50EDGAR2Form 4 - Statement of changes in beneficial ownership of..
21/12/202319:47EDGAR2Form 4 - Statement of changes in beneficial ownership of..
21/12/202315:05GLOBEClarion Clinics Receives Ethics Board Endorsement for the..
20/12/202316:05EDGAR2Form S-8 - Securities to be offered to employees in employee..
06/12/202306:30GLOBEIncannex Update on IHL-42X Drug Candidate in Phase 2/3..
29/11/202312:40GLOBEIncannex Healthcare Announces Completion of..
16/11/202308:38EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
16/11/202307:30GLOBEFederal Court of Australia Approves Incannex’s..
08/11/202305:07EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
26/10/202305:02EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
08/9/202306:30GLOBEIncannex Announces Participation at the H.C. Wainwright 25th..
08/9/202305:03EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
01/9/202307:43EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
24/8/202306:30GLOBEIncannex to Prepare FDA IND Application for..
22/8/202306:30GLOBEReview of IND Application for IHL-42X by US FDA has been..
08/8/202307:00GLOBEClarion Clinics Begins Accepting Registrations for..
08/8/202305:02EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
28/7/202306:30GLOBEIncannex Healthcare June 2023 Quarterly Activities Report..
26/7/202306:30GLOBEIncannex Completes Positive Pre-IND Meeting with US FDA on..
21/7/202308:09GLOBEIncannex Submits IND Application to the US FDA for IHL-42X..
18/7/202306:40GLOBEIncannex engages Fortrea to Manage its FDA IND Opening Phase..
13/7/202307:00GLOBEIncannex Receives HREC Approval for Phase 2 Clinical Trial..
13/7/202305:02EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
10/7/202307:43EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
10/7/202306:30GLOBEIncannex Announces Intention to Redomicile to United States,..
06/7/202307:42GLOBEIncannex Receives Ethics Approval for..
23/6/202307:00GLOBEIncannex Announces Participation at the H.C. Wainwright 4th..
16/6/202307:00GLOBEIncannex Appoints Principal Investigators for IHL-42X Phase..
30/5/202307:00GLOBEWorld Renowned International Psychedelics Experts Join..
16/5/202306:50GLOBEIncannex Company Presentation – Presentation of Psychennex,..
05/5/202306:30GLOBEIncannex enters a lease for first psychedelic-assisted..

Su Consulta Reciente

NASDAQ
IXHL
Incannex Healthcare
Delayed Upgrade Clock
ADVFN Logo

México
Empresa
Negocios
Popular
Obtener la aplicación

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones

© 2024 ADVFN PLC - Todos los derechos reservados